Pfizer Vaccine 3→Quarter 1

[사진=서울 명동에 위치한 화이자 코리아 본사. 뉴스1]
The government signed an additional purchase contract for 3 million Pfizer vaccines on the 15th. The supply period is expected to be advanced from 3Q to 1Q.

Worldwide, uncertainties in the production and supply of the COVID-19 vaccine are increasing. In particular, the amount of vaccines in the first half is limited.

Accordingly, in order to prepare for uncertainty, the government signed a contract to purchase 3 million additional Pfizer vaccines in addition to 10 million Pfizer vaccines, for a total of 13 million (26 million doses) of Pfizer vaccine.

Initially, the introduction period was scheduled in the third quarter, but early supply negotiations with pharmaceutical companies were underway, and 500,000 supplies will be supplied by the end of March, the first quarter, and 3 million people will be supplied in the second quarter.

Currently, the Pfizer vaccine is undergoing approval review by the Ministry of Food and Drug Safety, and vaccination is scheduled to begin in April when the national shipment approval for the vaccine introduced in late March is completed.

On the other hand, the Pfizer vaccine, which is separately imported through COVAX, is scheduled to be introduced in Korea from late February to early March.

Reporter Moon Se-young [email protected]

Copyrightⓒ’Honest Knowledge for Health’ Comedy.com (http://kormedi.com) / Unauthorized reproduction-redistribution prohibited


Source: 코메디닷컴 by kormedi.com.

*The article has been translated based on the content of 코메디닷컴 by kormedi.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!